Articles tagged with Egfr Activation
A new study has launched a novel blood test to identify people of Asian and Hispanic/Latinx descent who are at high risk of lung cancer but have never used tobacco. The trial aims to evaluate the feasibility of screening these individuals for free using CT scans, with the goal of detecting lung cancer at an early stage.
Researchers found that GZ17-6.02 killed uveal melanoma cells by enhancing autophagy, inactivating key proteins, and reducing growth factors. The compound also interacted with doxorubicin and ERBB inhibitors to enhance tumor cell killing, suggesting potential as a single agent or combination therapy.
A study reveals how mechanical constraints in glioblastoma tumors influence the emergence and spatial patterning of cancer stem cells. Piezo1 plays a crucial role in regulating mechanosensing and cell phenotypic switch.
Researchers report a case of a patient with EGFR L858R mutant non-small cell lung cancer (NSCLC) who experienced durable disease improvement after empirical treatment with osimertinib. The 'Lazarus effect' refers to the phenomenon where cancer appears to recur after seeming to be in remission.
Researchers from Korea University Medicine have discovered a potential therapeutic target for overcoming cisplatin resistance and neuropathic pain in cervical cancer. By inhibiting TRPV1, they found that resistant tumors became vulnerable to cisplatin, improving the outlook for patients.
Researchers found that BUB1 protein regulates EGFR signaling by reducing receptor internalization, which may lead to new therapeutic interventions for EGFR-driven cancers. The study also showed that BUB1 impacts receptor recycling and degradation, affecting signaling amplitude and duration.
A study found that activation of the epidermal growth factor receptor (EGFR)-mediated signaling pathway is involved in lenvatinib resistance in thyroid cancer cells. Inhibition of EGFR by lapatinib therapy in combination with lenvatinib enhanced growth inhibitory effect and inhibited tumor growth more remarkably than monotherapy.
Hippo signaling pathway's core components YAP and TAZ are activated by EGFR, promoting cell proliferation. Researchers uncover novel target for cancer therapies, combining EGFR targeting with YAP/TAZ inhibition.
The BEACON CRC trial demonstrated a survival advantage for patients with chemo-refractory BRAF mutant CRC treated with the combination of BRAF inhibitor encorafenib and EGFR inhibitor cetuximab. PLX8394, a paradox-breaker BRAF inhibitor, showed comparable efficacy to encorafenib in reducing pathway reactivation.
Researchers discovered that nimotuzumab promotes autophagic cell death, enhancing the antitumor effects of chemotherapy and radiation in ESCC cells with high EGFR expression. This finding suggests a potential strategy for improving therapeutic efficacy in esophageal squamous cell carcinoma.
A large cohort of KRAS exon 2 wild-type mCRC cases were screened for the S492R EGFR mutation without detection. This suggests that the S492R mutation is not involved in primary resistance to cetuximab in CRC, leading to a reevaluation of routine screening prior to treatment with cetuximab.
Researchers with Lawrence Berkeley National Laboratory and University of California Berkeley have provided new details on the activation of epidermal growth factor receptor (EGFR), a cell surface protein linked to many cancers. The study reveals structural coupling between EGFR transmembrane helix and extracellular juxtamembrane module...
Researchers discovered that TRPV3 plays a crucial role in regulating hair growth and skin health. The protein's activation leads to the release of TGF-alpha, which stimulates EGFR, forming a positive signaling loop.
Activation of EGFR stimulates AMP production, enhancing skin's antibacterial defense against Staphylococcus aureus. Wounding alone activates defense mechanisms to prevent microbial growth and related skin infections.
A recent study found that bainiku-ekisu inhibits AngII-induced EGF receptor transactivation and ERK activation in vascular smooth muscle cells, suggesting its potential as a new therapeutic agent for cardiovascular diseases like hypertension and atherosclerosis.